Last updated on June 2018

Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD)

Brief description of study

The purpose of the study is to evaluate the long-term safety and tolerability of SHP465 at 6.25 milligram (mg) in children aged 4 to 12 years diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD).

Clinical Study Identifier: NCT03325894

Contact Investigators or Research Sites near you

Start Over

Scott Segal

Scientific Clinical Research, Inc.
North Miami, FL United States
  Connect »

Armando Acevedo

Acevedo Medical Group
Miami, FL United States
  Connect »

Amol Malankar

Care Research Center
Doral, FL United States
  Connect »

Maria A. Carballosa

Power MD Clinical Research Institute
Hialeah, FL United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.